Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

First RayStation® Order in the United Kingdom

Published: Saturday, February 01, 2014
Last Updated: Saturday, February 01, 2014
Bookmark and Share
Ninewells to be the first clinical installation of RayStation® in the United Kingdom.

RaySearch Laboratories AB (publ.) has been awarded a contract to supply its RayStation® treatment planning system (TPS) to Tayside Cancer Centre, Ninewells Hospital & Medical School in Dundee, UK.

Ninewells Hospital & Medical School is one of the largest teaching hospitals in Europe. It has a comprehensive regional cancer centre serving the Tayside region of Scotland. The centre offers all forms of cancer therapy and treats approximately 1400 new cancer patients annually.

The radiotherapy department at Ninewells will replace its current TPS with RayStation®, as its treatment planning system for conventional 3D-CRT treatments, as well as more advanced treatments, such as IMRT and VMAT.

The order includes sophisticated solutions, such as multi-criteria optimization, enabling a more efficient treatment planning process. Multi-criteria optimization is a highly intuitive tool that lets the clinician evaluate the impact of changing different treatment priorities in real-time, which has a large potential to speed up the time-consuming plan optimization process.

The radiotherapy department at Ninewells Hospital will also implement dose tracking and adaptive planning using the dedicated tools available in RayStation, as well as investigating biological optimization and evaluation.

“NHS Tayside made the decision to purchase RayStation® following a comprehensive NHS Scotland procurement and evaluation process. The process took into consideration TPS generic specifications, site specific requirements by Tayside Cancer Centre and the benefits the system will bring to the centre over and above the competing systems. We look forward to working with the RaySearch team to produce the best possible treatment plans for patients”, says Salam Souliman, Head of RT Physics at Ninewells Hospital.

“The UK is a highly important market for us. We established our UK sales and service office in the second half of 2013 and this has already resulted in the first customer order. Ninewells is an excellent clinic and we are of course thrilled that they have now become our first UK customer”, says Johan Löf CEO of RaySearch.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
Nanomedicine for Breast Cancer Treatment
Using nanoparticles measuring only billionths of a meter in size, doctors are able to deliver drug molecules directly to the affected tissue.
Clamping Down on Biomolecules
Physicists have developed a novel nanotool that provides a means of characterizing the mechanical properties of biomolecules.
MRIs for Fetal Health
Algorithm could help analyze fetal scans to determine whether interventions are warranted.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.
Inflammation Test May Predict Cardiovascular Disease
An assessment combining measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos